120 related articles for article (PubMed ID: 33437066)
1. Author Correction: Establishment of patient-derived cancer organoids for drug-screening applications.
Driehuis E; Kretzschmar K; Clevers H
Nat Protoc; 2021 Dec; 16(12):5739. PubMed ID: 33437066
[No Abstract] [Full Text] [Related]
2. Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma.
Saito Y; Muramatsu T; Kanai Y; Ojima H; Sukeda A; Hiraoka N; Arai E; Sugiyama Y; Matsuzaki J; Uchida R; Yoshikawa N; Furukawa R; Saito H
Cell Rep; 2019 Apr; 27(4):1265-1276.e4. PubMed ID: 31018139
[TBL] [Abstract][Full Text] [Related]
3. Applications of kidney organoids derived from human pluripotent stem cells.
Kim YK; Nam SA; Yang CW
Korean J Intern Med; 2018 Jul; 33(4):649-659. PubMed ID: 29961307
[TBL] [Abstract][Full Text] [Related]
4. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
[TBL] [Abstract][Full Text] [Related]
5. Drug screening by uniform patient derived colorectal cancer hydro-organoids.
Jung YH; Choi DH; Park K; Lee SB; Kim J; Kim H; Jeong HW; Yang JH; Kim JA; Chung S; Min BS
Biomaterials; 2021 Sep; 276():121004. PubMed ID: 34273688
[TBL] [Abstract][Full Text] [Related]
6. Establishment and Long-Term Expansion of Small Cell Lung Cancer Patient-Derived Tumor Organoids.
Choi SY; Cho YH; Kim DS; Ji W; Choi CM; Lee JC; Rho JK; Jeong GS
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572899
[TBL] [Abstract][Full Text] [Related]
7. Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening.
Kim M; Mun H; Sung CO; Cho EJ; Jeon HJ; Chun SM; Jung DJ; Shin TH; Jeong GS; Kim DK; Choi EK; Jeong SY; Taylor AM; Jain S; Meyerson M; Jang SJ
Nat Commun; 2019 Sep; 10(1):3991. PubMed ID: 31488816
[TBL] [Abstract][Full Text] [Related]
8. [Establishment and application of gastric and gastric cancer organoids].
Fan S; Yin J; Wang M; Guan W
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1315-1320. PubMed ID: 30506544
[TBL] [Abstract][Full Text] [Related]
9. Patient-derived organoid (PDO) platforms to facilitate clinical decision making.
Liu L; Yu L; Li Z; Li W; Huang W
J Transl Med; 2021 Jan; 19(1):40. PubMed ID: 33478472
[TBL] [Abstract][Full Text] [Related]
10. Stem cell-derived kidney cells and organoids: Recent breakthroughs and emerging applications.
Chuah JKC; Zink D
Biotechnol Adv; 2017; 35(2):150-167. PubMed ID: 28017905
[TBL] [Abstract][Full Text] [Related]
11. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
[TBL] [Abstract][Full Text] [Related]
12. A synopsis of prostate organoid methodologies, applications, and limitations.
Gleave AM; Ci X; Lin D; Wang Y
Prostate; 2020 May; 80(6):518-526. PubMed ID: 32084293
[TBL] [Abstract][Full Text] [Related]
13. Organoid and Spheroid Tumor Models: Techniques and Applications.
Gunti S; Hoke ATK; Vu KP; London NR
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669619
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of prostate organoids from treatment-naïve patients with prostate cancer.
Cheaito K; Bahmad HF; Hadadeh O; Msheik H; Monzer A; Ballout F; Dagher C; Telvizian T; Saheb N; Tawil A; El-Sabban M; El-Hajj A; Mukherji D; Al-Sayegh M; Abou-Kheir W
Oncol Lett; 2022 Jan; 23(1):6. PubMed ID: 34820005
[TBL] [Abstract][Full Text] [Related]
15. [Establishment of a living biobank : Improved guidance of precision cancer care with in vitro and in vivo cancer models].
Pauli C; Moch H; Rubin MA
Pathologe; 2017 Nov; 38(Suppl 2):160-168. PubMed ID: 28956107
[TBL] [Abstract][Full Text] [Related]
16. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer.
Chen D; Tan Y; Li Z; Li W; Yu L; Chen W; Liu Y; Liu L; Guo L; Huang W; Zhao Y
J Clin Endocrinol Metab; 2021 Apr; 106(5):1410-1426. PubMed ID: 33524147
[TBL] [Abstract][Full Text] [Related]
17. [Kidney organoids].
Steichen C; Giraud S; Hauet T
Med Sci (Paris); 2019 May; 35(5):470-477. PubMed ID: 31115331
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response.
Frappart PO; Walter K; Gout J; Beutel AK; Morawe M; Arnold F; Breunig M; Barth TF; Marienfeld R; Schulte L; Ettrich T; Hackert T; Svinarenko M; Rösler R; Wiese S; Wiese H; Perkhofer L; Müller M; Lechel A; Sainz B; Hermann PC; Seufferlein T; Kleger A
United European Gastroenterol J; 2020 Jun; 8(5):594-606. PubMed ID: 32213029
[TBL] [Abstract][Full Text] [Related]
19. Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures.
Boehnke K; Iversen PW; Schumacher D; Lallena MJ; Haro R; Amat J; Haybaeck J; Liebs S; Lange M; Schäfer R; Regenbrecht CR; Reinhard C; Velasco JA
J Biomol Screen; 2016 Oct; 21(9):931-41. PubMed ID: 27233291
[TBL] [Abstract][Full Text] [Related]
20. Medium-Throughput Drug- and Radiotherapy Screening Assay using Patient-Derived Organoids.
Putker M; Millen R; Overmeer R; Driehuis E; Zandvliet MMJM; Clevers H; Boj SF; Li QX
J Vis Exp; 2021 Apr; (170):. PubMed ID: 33999032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
